MarketWatch The Wall Street Journal Digital Network Business Wire press release April 29, 2011, 5:07 p.m. EDT TROY, Mont., Apr 29, 2011 (BUSINESS WIRE) — In an April 22, 2011 letter to FDA Commissioner; Dr. Margaret Hamburg, Norma Erickson on behalf of the SaneVax Inc. Board of Directors, criticized the FDA for not following its own […]
SaneVax Letter to Dr. Margaret Hamburg, FDA Commissioner
April 22, 2011 Dear Dr. Hamburg: I have just read a press release issued by Roche announcing the FDA approval of its cobas HPV Test. The press release states “The cobas HPV Test is the only FDA-approved cervical cancer screening test that allows HPV 16 and 18 genotyping concurrently with high-risk HPV testing.” It is […]
Trial, and many errors
The Times of India Rema Nagarajan, TNN, Apr 23, 2011, 06.42am IST About 14,000 girls, aged between 10 and 14 years in the Khammam district of Andhra Pradesh were vaccinated with the human papilloma virus (HPV) vaccine as part of a study on the efficacy of the vaccine against cervical cancer last year. These girls […]
Pivotal Study Validates Roche’s cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer
By Basel ATHENA study shows the cobas HPV Test advances the standard of care by providing valuable information on the risks associated with the genotypes which cause 70 percent of cervical cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a study published online today in the American Journal of Clinical Pathology demonstrated the ability […]
FDA approves Roche HPV test to identify cervical cancer risk
Submitted by Mechele R. Dillard The U.S. Food and Drug Administration has approved a test identifying women at highest risk for cervical cancer. The U.S. Food and Drug Administration has approved the Roche cobas HPV(Human Papillomavirus) Test, which identifies women at highest risk for cervical cancer. It can potentially help doctors make earlier, more accurate […]
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 27
- Next Page »
